<- Go Home
Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Market Cap
EUR 14.5B
Volume
121.0K
Cash and Equivalents
EUR 573.8M
EBITDA
EUR 905.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 1.6B
Profit Margin
45.59%
52 Week High
EUR 267.70
52 Week Low
EUR 175.95
Dividend
0.31%
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
EUR 19.4B
Enterprise Value / EBITDA
20.60
Operating Income
EUR 583.9M
Return on Equity
6.18%
Return on Assets
3.65
Cash and Short Term Investments
EUR 573.8M
Debt
EUR 4.3B
Equity
EUR 3.9B
Revenue
EUR 3.6B
Unlevered FCF
EUR 415.1M
Sector
Life Sciences Tools and Services
Category
N/A